CSIG-03. PROLINE GLUTAMIC ACID AND LEUCINE RICH PROTEIN 1 (PELP1) PROMOTES GLIOBLASTOMA PROGRESSION VIA β-CATENIN PATHWAY

Glioblastomas (GBM) have dismal survival rates (1 year-34.6% and 5 year-4.75%) and affect 13,000 patients per year. Standard treatment consists of surgical resection, external beam radiation therapy, adjuvant chemotherapy with temozolomide and tumor treating fields. Nonetheless, despite a heavy inve...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Sareddy, Gangadhara Reddy, Zhou, Mei, Liu, Jinyou, Viswanadhapalli, Suryavathi, Gruslova, Aleksandra, Brann, Darrell, Brenner, Andrew, Vadlamudi, Ratna
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692510/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.198
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars